Triomune-30 is a tablet composition of Stavudine 30mg, Lamivudine 150mg and Nevirapine 200mg. Lamivudine and Stavudine belongs to a class of medication called nucleoside reverse transcriptase inhibitors. Lamivudine decreases the amount of virus (HIV and hepatitis) in the blood. Stavudine works by inhibiting multiplication of viruses thus decreasing their levels in the infected patient. Nevirapine belongs to a class of anti-HIV medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs).
USE OF TRIOMUNE-30 TABLETS
Triomune-30 tablet is a combination therapy for people with Human Immunodeficiency Virus (HIV) infection.
nausea/vomiting; diarrhoea; abdominal pain; loss of appetite; headache; dizziness; numbness, tingling, burning or pain in the hands or feet; blisters/mouth ulcers; tiredness; insomnia; muscle/joint pain; tremors;
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
IMPORTANT SAFETY INFORMATION
Consult your doctor before using this drug if:
- you have known liver or kidney problems, pancreatitis
- you are anaemic
- you are taking any other medication
Pregnancy: Potential risk to the foetus has been reported. Consult your doctor before use.
Breastfeeding: HIV infection can be passed to your baby through breast milk.